Navigation Links
FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
Date:2/28/2008

Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements, including, but not limited to, statements related to the planned commercial launch of LUVOX CR and Jazz Pharmaceuticals' continuing efforts, including manufacturing to prepare for commercial launch. Words and phrases such as "will," "are proceeding" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Jazz Pharmaceuticals' current expectations. Forward-looking statements involve significant risks and uncertainties. Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to when or whether commercial launch of LUVOX CR will occur, Jazz Pharmaceuticals' ability to attain market acceptance of LUVOX CR by physicians, patients and third party payors, Jazz Pharmaceuticals' dependence on single source suppliers and manufacturers, and scaling up manufacturing of LUVOX CR to commercial capacity. These and other risk factors are discussed under "Risk Factors," in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2007 filed by Jazz Pharmaceuticals with the Securities and Exchange Commission on November 9, 2007. Jazz Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

(C)2008 Jazz Pharmaceuticals, Inc. SODAS(R) is a registered trademark of Elan Pharma International Limited, Ireland, a subsidiary of Elan Corporation, plc (NYSE; ELN) LUVOX is a registered trademark of Solvay Pharmaceuticals, Inc.

(1) Davidson J, Yaryura-Tobias J, DuPont R, et al. Fluvoxamine-controlled

release formulation for the treatment of
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
2. U.S. Court Approves AK Steels VEBA Health Care Settlement With Middletown Works Retirees
3. Securian Board Approves 8 Officer Promotions
4. MGT Capital Investments, Inc. Approves Share Buyback Program
5. Kaiser Permanente Approves $29 Million in Community Benefit Grants
6. Otter Tail Corporation Reports Record Revenues and Net Income From Continuing Operations for 2007; Earnings Per Share of $1.78; Board Approves Dividend Increase
7. Pennsylvania Attorney General Approves Vincentian Collaborative System-Marian Manor Integration
8. FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
9. FDA Approves Additional Indication for Astellas MYCAMINE(R)
10. FDA Approves Labeling Change for Non-Drowsy CLARITIN(R)
11. FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... 2013 Americans live closer to their ... American Veterinary Medical Association (AVMA) U.S. Pet Ownership and ... consider their dog a member of the family, up ... much five years earlier. , According to the American ... national income dedicated to pets has increased every year ...
(Date:5/19/2013)... 19, 2013 Vegas Hotel Escapes, the ... to announce the launch it's all new vacation packages ... Grand on 5/19/2013. Consumers traveling to Las Vegas will ... available on VegasHotelEscapes.com's website. Travelers will be pleased to ... competitors price. , Vegas Hotel Escapes specializes in helping ...
(Date:5/19/2013)... 19, 2013 Passages Malibu, the leading ... has announced this week the launch of a “Sobriety, ... social media channels. “We are always looking for ... and to get feedback regarding sobriety, what’s working for ... co-founder of the Passages Addiction Treatment Centers ...
(Date:5/19/2013)... Beach, Florida (PRWEB) May 19, 2013 ... and market access, is pleased to unveil a new ... show environment that provides a powerful array of real-time ... partners in the US and abroad. , HE-Xpo is ... will offer attendees the look and feel of being ...
(Date:5/18/2013)... 2013 Cambridge House of Maryville , ... Metro East area, is hosting a Memorial Day Weekend Barbecue ... , The community, which is located at 6960 State Rte. ... including those on Medicaid, who need some help to maintain ... topped off by homemade ice cream for dessert,” says Tracy ...
Breaking Medicine News(10 mins):Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3Health News:Metro East Affordable Assisted Living Community to Host Memorial Day Weekend Barbecue 2
... , DENVER, Aug. 20 Clinic ... today the firm has secured an agreement to be the exclusive ... , "We are pleased to add a new client ... Dermatology and CSC are a great match for each other since ...
... moon for guidance, , THURSDAY, Aug. 20 (HealthDay News) -- ... unwittingly walking in circles for days. , Now, new research ... compass or a landmark, people trying to follow a straight ... where they started, according to a study published online Aug. ...
... ... of The Feinstein Institute for Medical Research has been awarded a prestigious $795,000 federal grant ... immune system to provide cutting-edge care to patients. , ... Manhasset, NY (Vocus) August 20, 2009 -- The Schneider Children,s Hospital ...
... drug used to treat type 2 diabetes, is associated with ... patients compared to a similar drug (pioglitazone), concludes a study ... researchers say it is difficult to advocate continued use of ... a class of drugs called thiazolidinediones and are widely used ...
... is funding a two year, 500,000 project to ... of new drugs to treat malaria. The ... Drug Discovery and Development Initiatives) is being led ... and brings together key players in the antimalarial ...
... 15 will still be useful, they stress , THURSDAY, Aug. ... the delay in receiving swine flu vaccine will thwart the ... virus. , But having only 45 million doses on hand ... doses, does throw a slight wrench into plans to vaccinate ...
Cached Medicine News:Health News:CSC Announces Agreement to Provide Billing Service to Colorado West Dermatology 2Health News:Lost Hikers, Backpackers Really Do Walk in Circles 2Health News:Lost Hikers, Backpackers Really Do Walk in Circles 3Health News:New Federal Training Grant to Teach Doctors/Scientists Immunology 2Health News:New Federal Training Grant to Teach Doctors/Scientists Immunology 3Health News:Diabetes drug linked to increased risk of heart failure 2Health News:LSTM to lead EU project to coordinate antimalarial drug research 2Health News:Swine Flu Vaccine Delay Manageable, Experts Say 2Health News:Swine Flu Vaccine Delay Manageable, Experts Say 3
(Date:5/18/2013)... The Open Paradigm Project, in collaboration ... Psychiatry , and leading organizations in the movement ... media campaign showcasing video testimonials by individuals negatively ... on pathology and illness rather than wellness and ... Association,s (APA) rollout of its latest revision of ...
(Date:5/17/2013)... , May 17, 2013  Lakeland Industries, Inc. ... of protective clothing for industry, healthcare and to first ... release its financial results for the fiscal 2013 fourth ... May 21, 2013 at stock market close and will ... 4:30 p.m. eastern. (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ...
(Date:5/17/2013)... Mass., May 17, 2013   Shareholder rights attorneys ... Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has filed a ... of Massachusetts .  The complaint alleges ... Securities Exchange Act of 1934 (the "Exchange Act") between ... Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
Breaking Medicine Technology:New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3
... leader in pain medication monitoring, today announced that ... Millennium Laboratories seeking damages, injunctive and other relief ... practices.  The Ameritox filing alleges that numerous Millennium ... the Lanham Act, unfair competition in accordance with ...
... Inc. (NYSE: WPI ), a leading specialty pharmaceutical ... first quarter 2012 financial results on Monday, April 30, 2012 ... Company will also host a conference call and webcast at ... its financial results and provide an update on the Company,s ...
Cached Medicine Technology:Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages 2Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages 3Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings 2
Medium clip size, 10mm...
Ethicon, medium clip size, 10mm, rotatable take apart...
Solid phase capture sandwich ELISA assay using a microwell format....
The C-Reactive Protein (CRP) assay is used for the quantitative analysis of C-reactive protein in human serum and plasma. Kit is for use with the Abbot Laboratories Aeroset, ARCHITECT c8000 or ARCHI...
Medicine Products: